Pixium Vision SA Performance
| PXMVFDelisted Stock | USD 1.50 1.47 4,900% |
The company holds a Beta of 0.0, which implies not very significant fluctuations relative to the market. the returns on MARKET and Pixium Vision are completely uncorrelated. Pixium Vision SA right now holds a risk of 0.0%. Please check Pixium Vision SA accumulation distribution and period momentum indicator , to decide if Pixium Vision SA will be following its historical price patterns.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days Pixium Vision SA has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable basic indicators, Pixium Vision is not utilizing all of its potentials. The current stock price disturbance, may contribute to mid-run losses for the stockholders. ...more
| Begin Period Cash Flow | 10.6 M | |
| Total Cashflows From Investing Activities | -52 K |
Pixium |
Pixium Vision Relative Risk vs. Return Landscape
If you would invest 150.00 in Pixium Vision SA on November 16, 2025 and sell it today you would earn a total of 0.00 from holding Pixium Vision SA or generate 0.0% return on investment over 90 days. Pixium Vision SA is currently producing negative expected returns and takes up 0.0% volatility of returns over 90 trading days. Put another way, 0% of traded pink sheets are less volatile than Pixium, and 99% of all traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
| Risk |
Pixium Vision Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Pixium Vision for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Pixium Vision SA can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Pixium Vision SA is not yet fully synchronised with the market data | |
| Pixium Vision SA may become a speculative penny stock | |
| Pixium Vision SA has a very high chance of going through financial distress in the upcoming years | |
| The company reported the revenue of 863 K. Net Loss for the year was (10.93 M) with profit before overhead, payroll, taxes, and interest of 1.79 M. | |
| Pixium Vision SA has accumulated about 10.13 M in cash with (8.83 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.22. |
Pixium Vision Fundamentals Growth
Pixium Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of Pixium Vision, and Pixium Vision fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Pixium Pink Sheet performance.
| Return On Equity | -5.77 | |||
| Return On Asset | -0.49 | |||
| Operating Margin | (6.17) % | |||
| Current Valuation | 8.32 M | |||
| Shares Outstanding | 58.7 M | |||
| Price To Book | 17.11 X | |||
| Price To Sales | 35.92 X | |||
| Revenue | 863 K | |||
| EBITDA | (9.69 M) | |||
| Cash And Equivalents | 10.13 M | |||
| Cash Per Share | 0.22 X | |||
| Total Debt | 6.5 M | |||
| Debt To Equity | 3.14 % | |||
| Book Value Per Share | 0.01 X | |||
| Cash Flow From Operations | (8.83 M) | |||
| Earnings Per Share | (0.24) X | |||
| Total Asset | 19.63 M | |||
About Pixium Vision Performance
By analyzing Pixium Vision's fundamental ratios, stakeholders can gain valuable insights into Pixium Vision's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Pixium Vision has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Pixium Vision has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Pixium Vision SA, a bioelectronics and brain machine interface technology company, specialized in neuromodulation application. Pixium Vision SA was founded in 2011 and is based in Paris, France. Eurofins Scientific operates under Medical Instruments Supplies classification in the United States and is traded on OTC Exchange. It employs 28 people.Things to note about Pixium Vision SA performance evaluation
Checking the ongoing alerts about Pixium Vision for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for Pixium Vision SA help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Pixium Vision SA is not yet fully synchronised with the market data | |
| Pixium Vision SA may become a speculative penny stock | |
| Pixium Vision SA has a very high chance of going through financial distress in the upcoming years | |
| The company reported the revenue of 863 K. Net Loss for the year was (10.93 M) with profit before overhead, payroll, taxes, and interest of 1.79 M. | |
| Pixium Vision SA has accumulated about 10.13 M in cash with (8.83 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.22. |
- Analyzing Pixium Vision's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Pixium Vision's stock is overvalued or undervalued compared to its peers.
- Examining Pixium Vision's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Pixium Vision's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Pixium Vision's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Pixium Vision's pink sheet. These opinions can provide insight into Pixium Vision's potential for growth and whether the stock is currently undervalued or overvalued.
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in small area income & poverty estimates. You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.
Other Consideration for investing in Pixium Pink Sheet
If you are still planning to invest in Pixium Vision SA check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Pixium Vision's history and understand the potential risks before investing.
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume |